Related Experiment Video
Updated: Jun 17, 2026
06:35
Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
Published on: March 29, 2024
L-carnitine modulates blood platelet oxidative stress
Joanna Saluk-Juszczak1, Beata Olas, Barbara Wachowicz
1Department of General Biochemistry, Institute of Biochemistry, University of Lodz, Lodz, Poland. juszczak@biol.uni.lodz.pl
Cell Biology and Toxicology
|January 14, 2010
Summary
L-carnitine may protect blood platelets from oxidative stress and reduce platelet activation. This study investigated L-carnitine
Area of Science:
- Biochemistry
- Hematology
- Exercise Physiology
Background:
- Oxidative stress from exertion can impair blood platelet function.
- L-carnitine's role in mitigating platelet oxidative stress requires further investigation.
- Existing research suggests L-carnitine influences platelet activity.
Purpose of the Study:
- To evaluate L-carnitine's impact on platelet activation markers.
- To assess L-carnitine's protective effects against oxidative and nitrative damage in platelets.
- To examine L-carnitine's influence on platelet antioxidant levels and reactive oxygen species.
Main Methods:
- In vitro study using resting and peroxynitrite-stimulated platelets.
- Assessed platelet activation via aggregation, superoxide anion radical (O2(-*)) formation, and lipid peroxidation (TBARS).
- Measured protein carbonyls, thiol groups, 3-nitrotyrosine residues, and glutathione levels.
Main Results:
- L-carnitine reduced platelet activation, including aggregation, O2(-*) generation, and TBARS production.
- Carnitine demonstrated a protective effect against peroxynitrite-induced oxidation of thiol groups.
- The compound influenced platelet glutathione levels and antioxidant status.
Conclusions:
- L-carnitine exhibits protective effects against oxidative damage in blood platelets.
- L-carnitine may modulate platelet function and reduce activation.
- Further research is warranted to explore L-carnitine's therapeutic potential in platelet-related disorders.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...